Amarex, an NSF International Company, Executes Five Rush COVID-19 Related Submissions to the FDA Ann Arbor, Mich., USA, April 02, 2020 (GLOBE NEWSWIRE) -- In early March 2020, Amarex Clinical Research LLC, an NSF International company, executed a rush submission of an emergency use...

Amarex, an NSF International Company, Executes Five Rush COVID-19 Related Submissions to the FDA Ann Arbor, April 02, 2020 (GLOBE NEWSWIRE) -- In early March 2020, Amarex Clinical Research LLC, an NSF International company, executed a rush submission of an emergency use Investigational New Drug...

NSF International Expands Health Science Services With Acquisition of Majority Interest in Amarex CRO ANN ARBOR, Mich., U.S., Oct. 09, 2019 (GLOBE NEWSWIRE) -- Global public health organization NSF International has acquired a majority interest in Amarex Clinical Research, LLC, a clinical stage...